Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.00
-0.05 (-0.62%)
Oct 8, 2024, 1:30 PM EDT - Market open
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $391.38 million as of October 8, 2024. Its market cap has decreased by -17.74% in one year.
Market Cap
391.38M
Enterprise Value
344.40M
1-Year Change
-17.74%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $391.38M, a decrease of -47.16%. That is a compound annual growth rate of -5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 4, 2024 | 396.30M | -29.19% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Butterfly Network | 397.51M |
| GRAIL | 397.43M |
| Organogenesis Holdings | 396.40M |
| MaxCyte | 395.59M |
| Talkspace | 395.30M |
| Biomea Fusion | 377.67M |
| Voyager Therapeutics | 370.28M |
| Canopy Growth | 370.02M |